Sartorius Korea
Sartorius Korea is the Korean subsidiary of German bioprocess equipment maker Sartorius AG, distributing integrated bioprocessing, laboratory instruments, and life science solutions to Korean biopharma manufacturers, research institutions, and quality control labs.
- Company typePrivate
- Founded2005
- HeadquartersSeongnam, South Korea
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Sartorius Korea does
Sartorius Korea operates as the wholly-owned Korean subsidiary of Sartorius AG (Goettingen, Germany; Frankfurt-listed under SRT3/SRT2), incorporated in 2005 and headquartered in Pangyo, Seongnam-si. The company distributes and supports an integrated bioprocess and laboratory product portfolio for Korean biopharmaceutical manufacturers, life science research institutions, and quality control laboratories, with a 2025 reported revenue of 298.1 billion KRW and approximately 220 employees across seven physical locations (Pangyo HQ and R&D center, Yongin service/KOLAS center, and branch offices in Daejeon, Gwangju, and Daegu). Revenue is generated through three primary streams: Bioprocess Solutions (BPS) hardware and consumables (chromatography systems and resins, single-use bioreactors and bags, cell culture media, filtration products), Lab Products & Services (LPS) including balances, pipettes, water purification systems, and microbiological testing consumables, and professional services (GLP-certified validation, biologics testing, cell banking, CRO testing, bioprocess consulting, and a training academy).
The technology stack is anchored by parent Sartorius AG's proprietary platforms, including Sartobind membrane chromatography (10x productivity improvement over protein A resin), Flexsafe single-use bags, Biostat STR and Ambr multi-parallel bioreactors, Octet biolayer interferometry and SPR systems, CIMmultus monolithic columns for gene therapy purification, Incucyte live-cell imaging, iQue high-throughput cytometry, and Umetrics multivariate data analytics. The Korean research institute at the Pangyo Global R&D Center conducts GLP-certified testing, process validation, biosafety testing, and cell banking services. The January 2026 GMP certification of its raw material manufacturing facility makes Sartorius Korea Biotech the first domestic producer of certified bioprocess raw materials in Korea. Distribution is multi-channel: direct enterprise field sales for large biopharma accounts, inside sales for inquiries and service requests, an eShop (shop.sartorius.com) for direct online purchasing, and a nationwide network of 12+ regional distributors covering all Korean provinces. Customer segments span biopharmaceutical manufacturers (primary), life science research institutions, quality control laboratories, and applied industries (battery R&D, food and beverage, environmental).
Sartorius Korea firmographics
Firmographics- Name
- Sartorius Korea
- Legal name
- Sartorius Korea Biotech Co., Ltd. (싸토리우스코리아바이오텍 유한회사)
- Website
- https://sartorius.co.kr
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Sartorius Korea is the Korean subsidiary of German bioprocess equipment maker Sartorius AG, distributing integrated bioprocessing, laboratory instruments, and life science solutions to Korean biopharma manufacturers, research institutions, and quality control labs.
- Ownership category
- akta.pro rank
Sartorius Korea industry classification
Industry- Product category
- Bioprocess Equipment and Life Science Instruments
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Testing Laboratories and Services (54138), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Laboratory Analytical Instruments (3826), Services-Testing Laboratories (8734), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI)
- akta.pro secondary industries
- Raw Materials & Critical Reagents Supply Services (media, resins, single-use) (HLAAAKAI), Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors) (HLAAAJAC), Analytical Development & QC Testing (Release/Stability/Potency) (HLAGAGAF), GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL), Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL)
Keywords
Where Sartorius Korea is headquartered
LocationHeadquarters
- HQ city
- Seongnam
- HQ country
- South Korea
- HQ region
- Asia
Offices7 records
Markets served
Sartorius Korea business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Bioprocess Solutions (BPS): Sale of bioprocess equipment and consumables including chromatography systems, bioreactors, filtration products, and cell culture media for biopharmaceutical manufacturing.
- Lab Products & Services (LPS): Sale of laboratory equipment including balances, water purification systems, pipettes, lab filtration and microbiology products.
- Validation and Testing Services: GLP-certified testing, process validation, non-clinical CRO, and cell banking services performed at the Korea research institute.
- Biologics Testing Services: Comprehensive biologics testing including cell line characterization, product characterization, lot release testing, and AAV testing services.
- Extractables and Leachables (E&L) Testing: Extractables and leachables testing using the Confidence platform for single-use system validation.
- Sartorius Service: Installation, commissioning, calibration, maintenance, repair, and training services for Sartorius equipment.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Bioprocess and lab equipment sales |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels11 records
Sartorius Korea product offering
Product offeringCore offering
Sartorius Korea sells bioprocess equipment and consumables (single-use bioreactors, chromatography systems and columns, filtration products, cell culture media, transfection reagents) and laboratory products (balances, pipettes, water purification, microbiological testing) to Korean biopharmaceutical manufacturers, life science researchers, and quality control laboratories. The company complements this hardware portfolio with GLP-certified validation, biologics testing, cell line development, bioprocess consulting, training, and equipment maintenance services delivered from its Pangyo headquarters and R&D center.
Product overview
Sartorius Korea provides an integrated portfolio of biopharmaceutical manufacturing equipment, consumables, and services. The core offerings include: biolayer interferometry (Octet® BLI) and surface plasmon resonance (Octet® SF3) for label-free analysis; bioreactors (Biostat® STR, Ambr®) for fermentation and cell culture; cell culture media (4Cell® SmartCHO) and reagents; membrane and resin chromatography (Sartobind®, CIMmultus®) for purification; process chromatography systems (Resolute® BioSMB) for batch and continuous operations; flow cytometry (iQue® 3) and live-cell imaging (Incucyte®) for analysis; and laboratory equipment including balances (Cubis® III), pipettes (Picus®), and water systems (Arium®). The portfolio is complemented by comprehensive services including CHO cell line development, validation services (Confidence®), bioprocess consulting, and training programs. The platform supports the entire biopharmaceutical workflow from discovery through commercial manufacturing.
Differentiator
Problem solved
Functional benefit
Products and services
- Octet BLI (Biolayer Interferometry)
Quantifiable outcome
- Up to 80% resin savings with continuous chromatography compared to batch chromatography
- +4 more outcomes
Companies that use Sartorius Korea
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
Sartorius Korea technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Sartorius Korea partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered regional and core.
- Daeheung Trading (대흥무역)regionalRegional distributor covering Busan area for lab products. Phone: 051-759-5766.
- Youngil Lab Plus (영인랩플러스)regionalRegional distributor covering Seoul area for Bio Process and Lab Products. Phone: 02-2140-5400.
- BS Gen (비에스젠)regionalRegional distributor covering Seoul area for Lab products. Phone: 02-2284-0100.
- Youngil Chromtech (영인크롬텍)regionalRegional distributor covering Seoul area for Lab products. Phone: 02-6207-1480.
- Bionics (바이오닉스)regionalRegional distributor covering Seoul area for Lab products. Phone: 02-6925-1625.
- Darwin Bio (다윈바이오)regionalRegional distributor covering Gyeonggi area for Bio Process and Lab Products. Phone: 1588-9741.
- Daehyun Tech (대현테크)regionalRegional distributor covering Gyeonggi area for Bio Process and Lab Products. Phone: 031-224-3241.
- Byunghyun Biotech (병현바이오텍)regionalRegional distributor covering Chungcheong area for Bio Process and Lab Products. Phone: 042-487-1801.
- BPT (비피티)regionalRegional distributor covering Gyeongsang/Jeju and Chungcheong areas for Bio Process and Lab Products. Phone: 044-863-5255.
- Microzyme (마이크로자임)regionalRegional distributor covering Jeonnam area for Bio Process and Lab Products. Phone: 061-363-0607.
- Jin Bio Science (진바이오사이언스)regionalRegional distributor covering Busan for Bio Process and Lab Products. Phone: 051-926-8885.
- Yuhan Hitech (유한하이텍)regionalRegional distributor covering South Gyeongsang for Lab Products. Phone: 055-277-5675.
- Charles River Laboratories (찰스리버)coreJoint seminar collaboration on aseptic testing and rapid microbiological detection methods. Partnership for customer education and seminar events in Korea.
- Cellca (German subsidiary of Sartorius)coreCellca, integrated into Sartorius in 2015, is the core cell line development platform (CHO cell line development) that underpins Sartorius's bioprocess service offerings globally, including Korea.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Sartorius Korea competitors and assessment
Company assessmentBroad incumbents
- Danaher Corporation: As parent of Cytiva and Pall, Danaher offers the closest integrated bioprocess competitor to Sartorius Korea at the workflow level, with overlap in single-use technology, filtration, and chromatography across Korean biopharma customers.
- Thermo Fisher Scientific: Thermo Fisher's Bioproduction and Laboratory Products divisions field a broad portfolio spanning bioreactors, single-use fluid management, cell culture media, lab equipment (pipettes, balances, water), and analytical instruments — competing with multiple Sartorius Korea product lines across customer accounts.
- Waters Corporation: Waters' chromatography systems, columns, and lab informatics compete with Sartorius Korea's process chromatography hardware and PAT/Umetrics analytics offerings for Korean pharmaceutical QC and bioprocess development budgets.
- Merck KGaA (MilliporeSigma): MilliporeSigma's BioPharma Process Solutions competes across the same bioprocess workflow — single-use bioreactors, filtration, chromatography media, raw materials — and also supplies analytical lab consumables, overlapping with essentially every category Sartorius Korea offers.
- Agilent Technologies: Agilent competes with Sartorius Korea's analytical instrument business (label-free detection, cell analysis) and supplies adjacent biopharma QC and process analytical tools commonly procured by the same Korean customers.
Direct peers
- Repligen Corporation: Repligen is a focused bioprocess pure-play competing head-on with Sartorius Korea's chromatography (OPUS pre-packed columns vs. Sartobind), single-use fluid management, and process filtration portfolios, frequently winning deals at Korean CDMOs and biologics manufacturers.
- Mettler-Toledo: Mettler-Toledo competes directly with Sartorius Korea's lab balances (Cubis III) and pipetting portfolio, and supplies weighing/instrumentation into the same Korean pharmaceutical and academic accounts.
- Cytiva: Cytiva (Danaher-owned, formerly GE Healthcare Life Sciences) is the closest direct competitor, offering parallel bioprocess equipment, single-use bioreactors, chromatography media/columns, and lab filtration/biacore-style analytical instruments — directly head-to-head with Sartorius's Flexsafe, Biostat, Sartobind, and Octet lines across Korean biopharma.
- Eppendorf: Eppendorf is a direct competitor in core lab equipment — electronic pipettes, centrifuges, bioreactors (BioFlo series), and lab consumables — sharing many of the same academic and biopharma R&D accounts in Korea.
Emerging players
- Lonza Group: Lonza is a CDMO/bioprocess services competitor with adjacent offerings in cell and gene therapy manufacturing and bioprocess services — overlapping with Sartorius Korea's biologics testing, AAV testing, and cell banking services for Korean developers outsourcing CMC work.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Sartorius Korea social profiles
Digital presenceSartorius Korea compliance and trust
Trust signalCompliance1 record
Sartorius Korea financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sartorius Korea leadership team
Management profileNumber of profiles
Sartorius Korea subsidiaries and ownership
Company hierarchySubsidiaries3 records
Sartorius Korea funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sartorius Korea M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sartorius Korea
What does Sartorius Korea do?
Sartorius Korea sells bioprocess equipment and consumables (single-use bioreactors, chromatography systems and columns, filtration products, cell culture media, transfection reagents) and laboratory products (balances, pipettes, water purification, microbiological testing) to Korean biopharmaceutical manufacturers, life science researchers, and quality control laboratories. The company complements this hardware portfolio with GLP-certified validation, biologics testing, cell line development, bioprocess consulting, training, and equipment maintenance services delivered from its Pangyo headquarters and R&D center.
Is Sartorius Korea a public or private company?
Sartorius Korea is a private company. It is classified as corporate owned and is currently operating.
When was Sartorius Korea founded?
Sartorius Korea was founded in 2005. It employs 101 to 250 people.
Where is Sartorius Korea based?
Sartorius Korea is headquartered in Seongnam, South Korea, in the Asia region.
How does Sartorius Korea make money?
Six revenue lines are on record. Bioprocess Solutions (BPS) is the primary driver. The others are lab Products & Services (LPS), validation and Testing Services, biologics Testing Services, extractables and Leachables (E&L) Testing and sartorius Service.
Who are Sartorius Korea's main competitors?
Broad incumbents on record are Danaher Corporation, Thermo Fisher Scientific, Waters Corporation, Merck KGaA (MilliporeSigma) and Agilent Technologies. Direct peers are Repligen Corporation, Mettler-Toledo, Cytiva and Eppendorf. Lonza Group is listed as an emerging player.
Does Sartorius Korea have an API?
No public API is recorded for Sartorius Korea.
What industry is Sartorius Korea in?
Sartorius Korea's product category is Bioprocess Equipment and Life Science Instruments. Its primary akta.pro industry code is HLAAAJAI, Bioprocess Consumables & Reagents (resins, membranes, media components, buffers), with a secondary code of HLAAAKAI, Raw Materials & Critical Reagents Supply Services (media, resins, single-use). Its NAICS code is 334516 and its SIC code is 3826.